In March 2020, Hannu Rajaniemi pivoted his biotech company Helix Nanotechnologies’ focus from cancer therapies to Covid-19 vaccines.
The role biotech start-ups can play in a pandemic
Rajaniemi originally co-founded Helix Nanotechnologies in Cambridge, Massachusetts in 2013 to develop cancer therapeutics, which was a personal mission: His mother got sick with and eventually passed due to metastatic breast cancer.
When the company pivoted to working on Covid-19 vaccines, he knew his start-up wouldn’t be one of the first vaccines out of the gate.
“That would have required billions in [Operation] Warp Speed funding,” Rajaniemi says. (HelixNano has received $6.4 million in total funding as of May, according to Crunchbase, from investors including Y Combinator, and has received grant money from Google billionaire Eric Schmidt’s Schmidt Futures.
“In this crisis, the role of a start-up is to pursue more technically challenging, second-generation approaches and find solutions that the less agile bigger players might miss,” he says.
While the first wave of Covid vaccines distributed in the United states from Pfizer/BioNTech, Moderna and Johnson & Johnson have to adapt their vaccines to new strains, HelixNano’s booster vaccine is designed to “provide much broader immunity,” he says.
“The reason we got into this … was that we were worried about mutated SARS-CoV-2 strains able to evade vaccine immunity,” Rajaniemi says. “That is exactly the scenario that is now playing out with the South African, Brazilian and other emerging variants.”
New vaccine technologies: Essentially ‘a zoom function and an amplify function’
Developing a vaccine that is resistant to virus mutations is “an extremely challenging problem technically,” Rajaniemi says.
But with the advantage of being able to build on all the knowledge scientists now have about the virus, HelixNano invented “two completely new vaccine technologies” for which they’ve filed for patents, according to Rajaniemi.
“Essentially, we have a ‘zoom’ function and an ‘amplify’ function for mRNA vaccines,” he says. (Both the Pfizer-BioNTech and Moderna vaccines are mRNA technology, as is Helix Nanotechnologies’ booster.)
“We can make vaccines both more targeted and more powerful than was previously possible,” says Rajaniemi.
The first technology Helix Nanotechnologies developed makes vaccines more accurate.
“Traditional vaccines are blunt instruments. You show the immune system a bit of the virus — like the spike protein that SARS-CoV-2 uses to infect cells — and [the body] generates antibodies against it,” Rajaniemi says. And “those antibodies are essentially random.”
However, HelixNano’s new technology directs antibodies at a very specific part of the virus’ spike protein that “matters the most for preventing infection,” according to Rajaniemi.
“To use a nerdy analogy, imagine the virus is the Death Star [space station from Star Wars]. To blow it up you need to hit a very small target — the thermal exhaust port,” says Rajaniemi (who is also a published science fiction author).
“Your X-Wings [starfighters] could just randomly fire at the whole Death Star, but you would have to get very, very lucky to destroy it,” he says.
“But if you concentrate all your fire on the exhaust port, you have a much better chance — even if your shots get less accurate as the virus mutates.”
The second vaccine technology HelixNano developed is a way to multiply the body’s immune response to a specific vaccine target by a factor of 100.
© Provided by CNBC
Taken together, these two technological advances are what HelixNano has used to build their Covid-19 mutation-resistant booster vaccine.
Beyond its own vaccine technology innovations, HelixNano is also collaborating with Louis Falo’s lab at University of Pittsburgh to make a vaccine technology that can be applied to the skin, rather than by a shot, which therefore can be self-administered.
“The mRNA platform has proven to be effective for vaccination, but does have limitations including the requirement for very low temperatures (cold-chain) across the storage, delivery, and deployment process,” says Falo, who is chairman of the dermatology department at the University of Pittsburgh and a bioengineering professor.
“We imagine an mRNA vaccine that is stable at room temperature and can therefore be readily deployed in global vaccination campaigns the same way that one would distribute and apply Band-Aids.”
(Separately, Falo’s lab has its own skin application vaccine called PittCoVacc, which has submitted preclinical data to the Food and Drug Administration as a Pre-Investigational New Drug Application application.)
Image Credit: CNBC
Post by Amanda Scott, NA CEO. Follow her on twitter @tantriclens
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen

News
Polaritons open up a new lane on the semiconductor highway
On the highway of heat transfer, thermal energy is moved by way of quantum particles called phonons. But at the nanoscale of today's most cutting-edge semiconductors, those phonons don't remove enough heat. That's why [...]
EU seeks agreement on world’s first AI law
The European Union will seek to thrash out an agreement on sweeping rules to regulate artificial intelligence on Wednesday, following months of difficult negotiations in particular on how to monitor generative AI applications like [...]
Lightning sparks scientists’ design of ultraviolet-C device for food sanitization
Scientists at the University of Illinois Urbana-Champaign have developed a portable, self-powered ultraviolet-C device called the Tribo-sanitizer that can inactivate two of the bacteria responsible for many foodborne illnesses and deaths. The Tribo-sanitizer's UVC [...]
3D Eye Scans Emerge as a Crucial Tool in Combating Kidney Disease
A new study indicates that 3D retinal scans could revolutionize the early detection and monitoring of kidney disease, offering a non-invasive and efficient diagnostic tool. 3D eye scans can reveal vital clues about kidney [...]
Researchers develop a blood test to identify individuals at risk of developing Parkinson’s disease
Research carried out at Oxford's Nuffield Department of Clinical Neurosciences has led to the development of a new blood-based test to identify the pathology that triggers Parkinson's disease before the main symptoms occur. This [...]
“Challenging the Paradigm” – Scientists Develop New Approach To Stop Cancer Growth
Biochemists at Case Western Reserve are concentrating on the degradation of a key protein that drives cancer; represents a major shift in research. Biochemical researchers at Case Western Reserve University have discovered a a new function [...]
Researcher develops a chatbot with an expertise in nanomaterials
A researcher has just finished writing a scientific paper. She knows her work could benefit from another perspective. Did she overlook something? Or perhaps there's an application of her research she hadn't thought of. [...]
Research shows human behavior guided by fast changes in dopamine levels
What happens in the human brain when we learn from positive and negative experiences? To help answer that question and better understand decision-making and human behavior, scientists are studying dopamine. Dopamine is a neurotransmitter [...]
Tiny robots made from human cells heal damaged tissue
The ‘anthrobots’ were able to repair a scratch in a layer of neurons in the lab. Scientists have developed tiny robots made of human cells that are able to repair damaged neural tissue1. The [...]
Antimicrobial Resistance – A Global Concern
Key facts Antimicrobial resistance (AMR) is one of the top global public health and development threats. It is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and contributed to [...]
Advancing Pancreatic Cancer Treatment with Nanoparticle-Based Chemotherapy
Pancreatic cancer, a particularly lethal form of cancer and the fourth leading cause of cancer-related deaths in the western world, often remains undiagnosed until its advanced stages due to a lack of early symptoms. [...]
The ‘jigglings and wigglings of atoms’ reveal key aspects of COVID-19 virulence evolution
Richard Feynman famously stated, "Everything that living things do can be understood in terms of the jigglings and wigglings of atoms." This week, Nature Nanotechnology features a study that sheds new light on the evolution of the coronavirus [...]
AI system self-organizes to develop features of brains of complex organisms
Cambridge scientists have shown that placing physical constraints on an artificially-intelligent system—in much the same way that the human brain has to develop and operate within physical and biological constraints—allows it to develop features [...]
How Blind People Recognize Faces via Sound
Summary: A new study reveals that people who are blind can recognize faces using auditory patterns processed by the fusiform face area, a brain region crucial for face processing in sighted individuals. The study employed [...]
Treating tumors with engineered dendritic cells
Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center (Heidelberg) have developed a novel immunotherapy that does not require knowledge of a tumor's antigenic makeup. The new results may pave the way [...]
Networking nano-biosensors for wireless communication in the blood
Biological computing machines, such as micro and nano-implants that can collect important information inside the human body, are transforming medicine. Yet, networking them for communication has proven challenging. Now, a global team, including EPFL [...]